2017
DOI: 10.1007/s40675-017-0096-x
|View full text |Cite
|
Sign up to set email alerts
|

Next Steps for Patients Who Fail to Respond to Cognitive Behavioral Therapy for Insomnia (CBT-I): the Perspective from Behavioral Sleep Medicine Psychologists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
10
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 37 publications
0
10
0
Order By: Relevance
“…The primary outcome was the ISI score, a validated, selfrating 7-item questionnaire assessing the severity of insomnia and associated daily life disturbances. 32 Total ISI scores ranged from 0 to 28, and were interpreted as follows: no clinically significant insomnia (0-7), subthreshold insomnia (8)(9)(10)(11)(12)(13)(14), moderate insomnia (15)(16)(17)(18)(19)(20)(21), and severe insomnia (22)(23)(24)(25)(26)(27)(28) (follow-up after the final intervention). 33 Secondary outcome measures included the following: (1) the Pittsburgh Sleep Quality Index (PSQI) score, (2) sleep diary-derived variables, (3) HADS score, (4) EuroQoL five dimension (EQ-5D) score, (5) Patient Global Impression of Change (PGIC) score, and (6) salivary melatonin and cortisol levels.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The primary outcome was the ISI score, a validated, selfrating 7-item questionnaire assessing the severity of insomnia and associated daily life disturbances. 32 Total ISI scores ranged from 0 to 28, and were interpreted as follows: no clinically significant insomnia (0-7), subthreshold insomnia (8)(9)(10)(11)(12)(13)(14), moderate insomnia (15)(16)(17)(18)(19)(20)(21), and severe insomnia (22)(23)(24)(25)(26)(27)(28) (follow-up after the final intervention). 33 Secondary outcome measures included the following: (1) the Pittsburgh Sleep Quality Index (PSQI) score, (2) sleep diary-derived variables, (3) HADS score, (4) EuroQoL five dimension (EQ-5D) score, (5) Patient Global Impression of Change (PGIC) score, and (6) salivary melatonin and cortisol levels.…”
Section: Discussionmentioning
confidence: 99%
“…Further, 25%-40% of insomnia patients do not achieve remission by CBT-I. 10,11 In addition, hypnotics are associated with diverse adverse effects such as residual daytime sedation, dizziness, drowsiness, nausea, mood changes, cognitive impairment, motor incoordination, and dependence. [12][13][14] Because of these limitations of conventional medicine, the use of complementary alternative medicine (CAM) for treating insomnia has increased from 20.6% in 1990 to 45% in 2007 in the United States.…”
Section: Introductionmentioning
confidence: 99%
“…progressive muscle relaxation) can be included in CBT‐I to reduce somatic tension or intrusive thoughts at bedtime (Morin et al, 2006). Although CBT‐I is effective and recommended to treat insomnia, there are ~40% of people who have no significant therapeutic gains after treatment (Baron & Hooker, 2017; Winkelman et al, 2020).…”
Section: Introductionmentioning
confidence: 99%
“…Up to 40% of insomnia patients do not adequately respond to CBT-I [ 10 ], likely due to insomnia heterogeneity [ 10 – 12 ]. For instance, insomnia patients with evening chronotype, unhelpful beliefs about sleep, short sleep, comorbidity, or high reactivity to stress may have a blunted response to CBT-I [ 12 15 ], possibly due to the influence of overactive neurobiological and psychological systems in insomnia pathophysiology [ 16 ]. Adherence to the therapeutic regime may also predict outcome [ 17 ].…”
Section: Introductionmentioning
confidence: 99%